| PD-L1 blockade enhances anti-tumor efficacy of NK cells JL Oyer, SB Gitto, DA Altomare, AJ Copik Oncoimmunology 7 (11), e1509819, 2018 | 130 | 2018 |
| Difluoromethylornithine combined with a polyamine transport inhibitor is effective against gemcitabine resistant pancreatic cancer SB Gitto, V Pandey, JL Oyer, AJ Copik, FC Hogan, O Phanstiel IV, ... Molecular pharmaceutics 15 (2), 369-376, 2018 | 44 | 2018 |
| An autologous humanized patient-derived-xenograft platform to evaluate immunotherapy in ovarian cancer SB Gitto, H Kim, S Rafail, DK Omran, S Medvedev, Y Kinose, ... Gynecologic Oncology 156 (1), 222-232, 2020 | 42 | 2020 |
| Constitutively active Akt1 cooperates with KRasG12D to accelerate in vivo pancreatic tumor onset and progression TM Albury, V Pandey, SB Gitto, L Dominguez, LP Spinel, J Talarchek, ... Neoplasia 17 (2), 175-182, 2015 | 38 | 2015 |
| CAR T cells targeting MISIIR for the treatment of ovarian cancer and other gynecologic malignancies A Rodriguez-Garcia, P Sharma, M Poussin, AC Boesteanu, NG Minutolo, ... Molecular Therapy 28 (2), 548-560, 2020 | 31 | 2020 |
| Parp theranostic auger emitters are cytotoxic in brca mutant ovarian cancer and viable tumors from ovarian cancer patients enable ex-vivo screening of tumor response A Riad, SB Gitto, H Lee, HD Winters, PM Martorano, CJ Hsieh, K Xu, ... Molecules 25 (24), 6029, 2020 | 23 | 2020 |
| Anti-ovarian tumor response of donor peripheral blood mononuclear cells is due to infiltrating cytotoxic NK cells V Pandey, JL Oyer, RY Igarashi, SB Gitto, AJ Copik, DA Altomare Oncotarget 7 (6), 7318, 2016 | 23 | 2016 |
| Differential expression of polyamine pathways in human pancreatic tumor progression and effects of polyamine blockade on tumor microenvironment SP Nakkina, SB Gitto, V Pandey, JG Parikh, D Geerts, HC Maurer, ... Cancers 13 (24), 6391, 2021 | 22 | 2021 |
| Identification of a novel IL-5 signaling pathway in chronic pancreatitis and crosstalk with pancreatic tumor cells SB Gitto, JM Beardsley, SP Nakkina, JL Oyer, KA Cline, SA Litherland, ... Cell Communication and Signaling 18, 1-14, 2020 | 22 | 2020 |
| Cryopreserved PM21-particle-expanded natural killer cells maintain cytotoxicity and effector functions in vitro and in vivo JL Oyer, TJ Croom-Perez, TA Dieffenthaller, LD Robles-Carillo, SB Gitto, ... Frontiers in Immunology 13, 861681, 2022 | 13 | 2022 |
| [18F]FluorThanatrace ([18F]FTT) PET Imaging of PARP-Inhibitor Drug-Target Engagement as a Biomarker of Response in Ovarian Cancer, a Pilot Study AR Pantel, SB Gitto, M Makvandi, H Kim, S Medvedv, JK Weeks, ... Clinical Cancer Research 29 (8), 1515-1527, 2023 | 11 | 2023 |
| Recent insights into the pathophysiology of mTOR pathway dysregulation SB Gitto, DA Altomare Research and Reports in Biology, 1-16, 2015 | 9 | 2015 |
| Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma M Makvandi, M Samanta, P Martorano, H Lee, SB Gitto, K Patel, D Groff, ... Communications Biology 5 (1), 1260, 2022 | 7 | 2022 |
| Humanized patient-derived xenograft models of ovarian cancer SB Gitto, E George, S Medvedev, F Simpkins, DJ Powell Ovarian Cancer: Methods and Protocols, 255-274, 2022 | 5 | 2022 |
| Induction of pancreatitis in mice with susceptibility to pancreatic cancer SB Gitto, SP Nakkina, JM Beardsley, JG Parikh, DA Altomare Methods in Cell Biology 168, 139-159, 2022 | 4 | 2022 |
| Dfmo improves survival and increases immune cell infiltration in association with myc downregulation in the pancreatic tumor microenvironment SP Nakkina, SB Gitto, JM Beardsley, V Pandey, MW Rohr, JG Parikh, ... International journal of molecular sciences 22 (24), 13175, 2021 | 4 | 2021 |
| Leveraging immune resistance archetypes in solid cancer to inform next-generation anticancer therapies KG Anderson, DA Braun, A Buqué, SB Gitto, JL Guerriero, B Horton, ... Journal for immunotherapy of cancer 11 (6), 2023 | 3 | 2023 |
| Effect of PDL1 signaling blockade on NK cell cytolytic activity towards ovarian cancer. J Oyer, SB Gitto, D Altomare, R Igarashi, A Copik Journal of Clinical Oncology 36 (5_suppl), 13-13, 2018 | 2 | 2018 |
| Assessment of antitumor function of NK cells expanded with exosomes from K562. mb21 cells. J Oyer, SB Gitto, S Khederzadeh, K Shaver, DA Lee, D Altomare, A Copik Journal of Clinical Oncology 35 (7_suppl), 132-132, 2017 | 2 | 2017 |
| CD137+ tumor infiltrating lymphocytes predicts ovarian cancer survival EA Tubridy, MA Eiva, F Liu, DK Omran, S Gysler, EG Brown, AG Roy, ... Gynecologic Oncology 184, 74-82, 2024 | 1 | 2024 |
Deborah AltomareUniversity of Central FloridaVerified email at ucf.edu
